Nefrogen systemic fibrosis is reported in a dialysis patient after MR-angiography with a contrast medium;Nefrogen systemisk fibrose hos en dialy-sepatient efter MR-angiografi med kontraststof

Ugeskrift for Laeger

Volumn 170, Issue 8, 2008, Pages 655-

  Matthesen, Solveig Klok ^a,b   Pedersen, Erling Bjerregaard ^a  

^a Medicinsk Forskning og Medicinsk Afdeling

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ARTHROPATHY; ARTICLE; CASE REPORT; FEMORAL ARTERY; FIBROSIS; HUMAN; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PATHOLOGY; RENAL REPLACEMENT THERAPY; SKIN;

CONTRAST MEDIA; FEMORAL ARTERY; FIBROSIS; HUMANS; JOINT DISEASES; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; RENAL DIALYSIS; SKIN;

EID: 41649115810     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Cowper SE, Robin HS, Steinberg SM et al. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000;356:1000-1.
2. Ting WW, Stone MS, Madison KC et al. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 2003;139:903-6.
3. Daram SR, Cortese CM, Bastani B. Nephrogenic fibrosing dermopathy/ nephrogenic systemic fibrosis: report of a new case with literature review. Am J Kidney Dis 2005;46:754-9.
4. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006;21:1104-8.
5. Marckmann P, Skov L, Rossen K et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006;17:2359-62.